Safety Policy (Estradiol)

Compounded Estradiol Pills: Important Safety Information

Compounded estradiol is a prescription medication containing estrogen. A licensed healthcare provider will evaluate whether treatment is appropriate based on your symptoms, medical history, and individual risks. A consultation does not guarantee a prescription.

FDA status and compounding considerations

Compounded estradiol is not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. Compounding errors may result in contamination or too much or too little medication. FDA-approved oral estradiol products are available; your provider should explain why a compounded formulation is appropriate for your medical needs. FDA compounding information

“Bioidentical,” “natural,” or “customized” does not mean a product is safer or more effective. Compounded hormone therapy has not been shown to be safer or more effective than FDA-approved hormone therapy. ACOG recommends FDA-approved menopausal hormone therapy over compounded preparations when approved options meet the patient’s needs. ACOG guidance

How estradiol works

Estradiol binds to estrogen receptors throughout the body. It replaces estrogen that declines during menopause and can help relieve symptoms such as hot flashes and night sweats. A swallowed pill produces systemic effects, meaning it acts throughout the body. Estradiol prescribing information

Important warnings

  • Uterine cancer: Taking systemic estrogen without adequate progesterone or another progestogen increases the risk of endometrial cancer, which affects the uterine lining. If you have a uterus, your provider will generally prescribe a progestogen alongside estradiol to reduce this risk. Report unusual vaginal bleeding promptly, particularly after menopause.

  • Blood clots and cardiovascular events: Systemic hormone therapy may increase the risk of blood clots, stroke, and heart attack. Your individual risk depends on your health history and treatment regimen.

  • Breast cancer: Estrogen combined with a progestogen can increase breast cancer risk. The risk with estrogen alone differs and should be discussed separately with your provider. FDA menopause safety information

Other serious estrogen-related risks include gallbladder disease, elevated triglycerides that may lead to pancreatitis, liver problems, and severe allergic reactions. Studies of certain estrogen-plus-progestin regimens in women age 65 and older found an increased risk of probable dementia; those findings do not establish the risk for this specific compounded pill. FDA hormone-therapy labeling

Who should not use this medication

For menopausal treatment, do not use compounded estradiol if you have:

  • Unexplained vaginal bleeding.

  • Known or suspected breast cancer, a history of breast cancer, or another estrogen-dependent cancer.

  • Current or previous blood clots in the legs or lungs.

  • A history of stroke or heart attack.

  • A known inherited condition that increases blood-clot risk.

  • Liver disease.

  • An allergy to estradiol or another ingredient in the formulation.

Do not use during pregnancy or if pregnancy is suspected. Estradiol prescribing information, FDA estrogen-related contraindications

Possible side effects

Possible effects include breast tenderness, nausea, stomach discomfort, bloating, headaches, dizziness, spotting or irregular bleeding, fluid retention, and changes in mood or sexual desire. Tell your provider about persistent or bothersome symptoms. Side-effect rates for your specific compounded formulation may not be known. Estrogen patient information, Estradiol labeling

Precautions and interactions

Tell your provider about smoking, high blood pressure, diabetes, migraines, high triglycerides, thyroid disease, kidney disease, gallbladder problems, endometriosis, and any personal or family history of blood clots or cancer. Estrogen precautions

Tell your provider before surgery or prolonged immobility; temporary interruption may be necessary. If you take thyroid replacement medication, additional monitoring or adjustment may be needed. Discuss breastfeeding before treatment because estrogen may reduce milk production. FDA hormone-therapy precautions

Provide a complete list of medicines and supplements. Interactions may occur with certain seizure medicines, rifampin, some antibiotics and antifungals, St. John’s wort, and grapefruit products. Estrogen-containing therapy may also interfere with lamotrigine treatment. Do not change medications without your prescriber’s guidance. Estradiol interactions, Lamotrigine labeling

Safe use and follow-up

Swallow the medication exactly as prescribed. Follow the pharmacy’s storage instructions and beyond-use date. Never share medication.

Attend follow-up appointments to reassess benefits, side effects, and continued treatment needs. Keep recommended breast screening current.

Estradiol hormone replacement therapy is not birth control. Discuss contraception if pregnancy is possible. NHS hormone-therapy information

When to get medical help

Call 911 immediately for chest pain, sudden shortness of breath, coughing up blood, facial drooping, one-sided weakness, difficulty speaking, sudden loss of vision, or difficulty breathing with facial or throat swelling. Do not wait for a telehealth response.

Seek urgent evaluation for new pain or swelling in one leg. Contact your provider promptly for unusual vaginal bleeding, a breast lump, yellowing of the skin or eyes, or severe abdominal pain. Estrogen emergency symptoms

This information does not include every possible risk or interaction. It does not replace individualized medical advice or instructions from your prescriber and dispensing pharmacy.